A phase I randomised, repeat patch application study in healthy male volunteers, to determine the pharmacokinetic profile of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).

Trial Profile

A phase I randomised, repeat patch application study in healthy male volunteers, to determine the pharmacokinetic profile of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Feb 2010 Positive results reported in a Phosphagenics media release.
    • 02 Feb 2010 Status changed from recruiting to completed, according to a Phosphagenics media release.
    • 03 Dec 2009 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top